SEARCH

SEARCH BY CITATION

References

  • Bourhis, J.H., Bouko, Y., Koscielny, S., Bakkus, M., Greinix, H., Derigs, G., Salles, G., Feremans, W., Apperley, J., Samson, D., Bjorkstrand, B., Niederwieser, D., Gahrton, G., Pico, J.L. & Goldschmidt, H. (2007) Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. Haematologica, 92, 10831090.
  • Durie, B.G., Harousseau, J.L., Miguel, J.S., Blade, J., Barlogie, B., Anderson, K., Gertz, M., Dimopoulos, M., Westin, J., Sonneveld, P., Ludwig, H., Gahrton, G., Beksac, M., Crowley, J., Belch, A., Boccadaro, M., Cavo, M., Turesson, I., Joshua, D., Vesole, D., Kyle, R., Alexanian, R., Tricot, G., Attal, M., Merlini, G., Powles, R., Richardson, P., Shimizu, K., Tosi, P., Morgan, G. & Rajkumar, S.V. (2006) International uniform response criteria for multiple myeloma. Leukemia, 20, 14671473.
  • Hiwase, D.K., Hiwase, S., Bailey, M., Bollard, G. & Schwarer, A.P. (2008) Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biology of Blood Marrow Transplantation, 14, 116124.
  • Morineau, N., Tang, X.W., Moreau, P., Milpied, N., Mahe, B., Bataille, R. & Harousseau, J.L. (2000) Lack of benefit of CD34+ cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single center study. Leukemia, 14, 18151820.
  • O'Shea, D., Giles, C., Terpos, E., Perz, J., Politou, M., Sana, V., Naresh, K., Lampert, I., Samson, D., Narat, S., Kanfer, E., Olavarria, E., Apperley, J.F. & Rahemtulla, A. (2006) Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. Bone Marrow Transplantation, 37, 731737.
  • Porrata, L.F., Gertz, M.A., Geyer, S.M., Litzow, M.R., Gastineau, D.A., Moore, S.B., Pineda, A.A., Bundy, K.L., Padley, D.J., Persky, D., Lacy, M.Q., Dispenzieri, A., Snow, D.S. & Markovic, S.N. (2004) The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia, 18, 10851092.
  • Vescio, R., Schiller, G., Stewart, A.K., Ballester, O., Noga, S., Rugo, H., Freytes, C., Stadtmauer, E., Tarantolo, S., Sahebi, F., Stiff, P., Meharchard, J., Schlossman, R., Brown, R., Tully, H., Benyunes, M., Jacobs, C., Berenson, R., DiPersio, J., Anderson, K. & Berenson, J. (1999) Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood, 93, 18581868.